ASH Image Bank (2001); doi:10.1182/ashimagebank-2001-100188
Copyright © 2001 by the American Society of Hematology.
Myeloid Neoplasms. Myelodysplastic Syndrome: Refractory Ctyopenia with Multilineage Dysplasia
James W Vardiman, M.D.
University of Chicago

View larger version (128K):
[in this window]
[in a new window]
|
Figure 1. Refractory cytopenia with multilineage dysplasia (RCMD). Peripheral blood smear (Wright-Giemsa stain). This composite photograph shows representative fields of the blood smear. Occasional macro-ovalocytes are seen. Some neutrophils have peculiar nuclear segmentation. There is thrombocytopenia. Blasts were not identified in the blood smear.
|
|

View larger version (165K):
[in this window]
[in a new window]
|
Figure 2. Refractory cytopenia with multilineage dysplasia (RCMD). Bone marrow biopsy (H & E stain). The bone marrow biopsy specimen shows normally cellular bone marrow.
|
|

View larger version (127K):
[in this window]
[in a new window]
|
Figure 3. Refractory cytopenia with multilineage dysplasia (RCMD). Bone marrow biopsy (H & E stain). The biopsy demonstrates erythroid hyperplasia. Immature erythroid precursors (arrows) have round to oval vesicular nuclei, a prominent, comma-shaped nucleolus that often is close to the nuclear membrane, and a rim of amphophilic cytoplasm. Erythroid precursors that are more mature (double arrows) have homogenous, darkly-stained nuclei.
|
|

View larger version (133K):
[in this window]
[in a new window]
|
Figure 5. Refractory cytopenia with multilineage dysplasia (RCMD). Bone marrow biopsy (H&E stain). This photomicrograph illustrates an abnormally small megakaryocyte with hypolobated nucleus. Note the dense, pink-staining cytoplasm.
|
|

View larger version (107K):
[in this window]
[in a new window]
|
Figure 6. Refractory cytopenia with multilineage dysplasia (RCMD). Bone marrow aspirate smear (Wright-Giemsa stain). This composite illustrates typical fields from the bone marrow aspirate. In the photograph on the left side, the arrows point to dyspoietic erythroid precursors, with abnormally shaped nuclei. In the photograph on the right, an abnormal neutrophil with a hypolobated nucleus is seen at the arrow, and an abnormal megakaryocyte is also present (double arrow). More than 30% of the erythroid precursors and over one-half of the megakaryocytes in the specimen were dysplastic. Relatively few (~10%) of the neutrophils show abnormalities. Note that there is no increase in the number of blasts, which totaled 3% in a 500-cell differential performed on the aspirate smear.
|
|

View larger version (104K):
[in this window]
[in a new window]
|
Figure 7. Refractory cytopenia with multilineage dysplasia (RCMD). Bone marrow aspirate smear (Wright-Giemsa stain). In the left panel of this figure, abnormal megakaryocytes that are small with hypolobated nuclei are seen. In the right panel, some dysplastic erythroid precursors are noted. A single blast with a few fine azuorphil granules is seen (arrow).
|
|

View larger version (125K):
[in this window]
[in a new window]
|
Figure 8. Refractory cytopenia with multilineage dysplasia (RCMD). Bone marrow aspirate smear (Iron stain). No ringed sideroblasts were noted on the iron stain.
|
|

View larger version (103K):
[in this window]
[in a new window]
|
Figure 9. Refractory cytopenia with multilineage dysplasia (RCMD). Bone marrow aspirate smear (Wright-Giemsa stain). This composite of an aspirate smear is from a different patient, but also illustrates multilineage dysplasia. Hypogranular neutrophils (arrows) and an abnormal, small megakaryocyte (double arrows) are readily appreciated.
|
|

View larger version (43K):
[in this window]
[in a new window]
|
Figure 10. Refractory cytopenia with multilineage dysplasia (RCMD). Cytogenetic preparation. The karyotype performed from bone marrow cells was: 46, XY [80%] 46, XY, del (5q)(q11q33), del (7q)(q11q36) [20%].
|
|
 |
Clinical Summary
|
|---|
This 65 year old man presented with gradual onset of fatigue and shortness
of breath. A CBC showed WBC=2.0 x 109/L, with 40% neutrophils, Hb=7.2g/dl, and
platelets=49 x 109/L. The patient gave no history of drug or alcohol abuse,
and was on no medications. Studies for B12, serum folate and serum ferritin
were normal. A bone marrow biopsy and aspiration were performed, and a specimen
was submitted for cytogenetic analysis. He has had no improvement in his blood
counts after a 6 month period of observation.
Sex
Male
Age
65
Ethnicity
n/a
 |
Diagnosis
|
|---|
Myelodysplastic Syndrome (MDS), Refractory Cytopenia with Multilineage Dysplasia
 |
Discussion
|
|---|
Definition of RCMD (WHO): Refractory cytopenia with multilineage dysplasia
(RCMD) is a myelodysplastic syndrome (MDS) with bi- or pancytopenia, and dysplastic
changes in 10% or more of the cells in two or more myeloid cell lines (granulocytes,
erythroid, and/or megakaryocytes). There are < 1% blasts in the blood and less
than 5% blasts in the bone marrow. Auer rods are not present and monocytes in
the blood are < 1 x 10^9/L. If ringed sideroblasts are more than 15% of
the erythroid precursors, the designation of Refractory cytopenia with multilineage
dysplasia and ringed sideroblasts (RCMD-RS) should be made.
Synonyms: Myelodysplastic syndrome, unclassifiable (FAB). Some cases
may have been previously included in the FAB subgroups of refractory anemia
or refractory anemia with ringed sideroblasts.
Epidemiology: Occurs mainly in older individuals. It accounts for approximately
20-30% of all cases of MDS.
Etiology: The etiology of primary (de novo) RCMD is unknown. A history
of exposure to toxins, such as benzene, pesticides, and other chemicals has
been correlated with an increased incidence of MDS in some populations examined.
Cigarette smoking increases the risk by about two-fold. A significant number
of patients who have therapy-related MDS may initially present with the features
of RCMD.
Clinical features: Most patients present with symptoms related to one
or more of the cytopenias.
Morphology: The diagnosis of RCMD can be made when blasts account for
fewer than 1% of the white cells in the blood, and monocytes are < 1 x 10^9/L.
In the bone marrow, blasts number fewer than 5% of the marrow cells, and Auer
rods are not found. Dysplastic changes are present in >10% of the cells in two
or more myeloid cell lines. The dysplasia is often marked in one or more of
the lineages. Neutrophils in the blood and/or bone marrow may hypogranulation
of their cytoplasm or nuclear abnormalities, including nuclear hyposegmentation
(pseudo Pelger-Huet change), bizarrely segmented nuclei, and hypercondensation
of nuclear chromatin. Erythroid precursors in the bone marrow can show cytoplasmic
vacuoles, nuclear irregularity with multilobation, multinucleation, and megaloblastoid
nuclei. If ringed sideroblasts are not seen or account for fewer than 15% of
the erythroid precursors, the designation of RCMD is made. If 15% or more of
the erythroid precursors are ringed sideroblasts, the diagnosis is RCMD-RS.
Megakaryocytic abnormalities may include hypolobulation of nuclei, widely separated
nuclear lobes, and/or micromegakaryocytes.
Genetics: Clonal chromosomal abnormalities are found in nearly one-half
of the patients, and may include +8, del(7/7q), del(20q), del(5/5q), as well
as complex abnormalities.
Clinical Outcome: The median survival times reported for patients with
RCMD has varied from approximately 20 to 35 months. Patients may progress to
higher grades of MDS, or to overt acute myeloid leukemia, but many will die
of complications of their bone marrow failure.
 |
Differential Diagnosis
|
|---|
The differential diagnosis includes secondary, non-clonal causes of multilineage
dysplasia that may occur in a number of disorders, including HIV-related disease,
heavy metal (particularly arsenic) poisoning, and after therapy with some cytotoxic
drugs and cytokines. However, the major differential diagnoses of RCMD is with
other myelodysplastic syndromes, particularly RA, RARS, and RAEB-1. The distinguishing
features between these entities are listed in Table 2 above. In addition, the
Myelodysplastic/Myeloproliferative disease, Chronic myelomonocytic leukemia
(CMML)

CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| Related Image Bank Image Sets |  |  |
-
Myelodysplastic Syndrome: Refractory Anemia with Ringed Sideroblasts (RARS)
- James W Vardiman
ASH Image Bank 2001 2001: 100189.
[Full Text]
-
Myelodysplastic Syndrome: Myelodysplastic Syndrome Associated with Isolated del(5q)Chromosome Abnormality ('5q- Syndrome')
- James W Vardiman
ASH Image Bank 2001 2001: 100197.
[Full Text]
-
Myelodysplastic syndrome
- Peter Maslak
ASH Image Bank 2002 2002: 100391.
[Full Text]
-
Myelodysplastic syndrome
- Peter Maslak
ASH Image Bank 2002 2002: 100458.
[Full Text]
-
Myelodysplastic syndrome
- Peter Maslak
ASH Image Bank 2002 2002: 100467.
[Full Text]
-
Myelodysplastic Syndrome
- Stanley Schrier
ASH Image Bank 2002 2002: 100508.
[Full Text]
-
Pseudo Pelger Huet Cells (II)
- Peter Maslak and Susan McKenzie
ASH Image Bank 2002 2002: 100527.
[Full Text]
-
Chronic Myelomonocytic Leukemia
- Peter Maslak and Susan McKenzie
ASH Image Bank 2002 2002: 100542.
[Full Text]
-
Hypersegmented Neutrophil
- Peter Maslak
ASH Image Bank 2003 2003: 100602.
[Full Text]
-
Acute Myeloblastic Leukemia With Maturation
- Peter Maslak
ASH Image Bank 2003 2003: 100722.
[Full Text]
-
Chronic Myelomonocytic Leukemia
- Peter Maslak
ASH Image Bank 2003 2003: 100836.
[Full Text]
-
Acute Myeloid Leukemia without Maturation
- Peter Maslak
ASH Image Bank 2003 2003: 100838.
[Full Text]
-
Atypical CML
- Peter Maslak
ASH Image Bank 2003 2003: 100871.
[Full Text]
-
Erythroid Dysplasia
- Peter Maslak
ASH Image Bank 2003 2003: 100895.
[Full Text]
-
Atypical CML
- Peter Maslak
ASH Image Bank 2003 2003: 100899.
[Full Text]
-
Chronic Myelomonocytic Leukemia
- Peter Maslak
ASH Image Bank 2003 2003: 100903.
[Full Text]
-
Refractory Anemia With Excess Blasts (RAEB-1)
- Peter Maslak
ASH Image Bank 2003 2003: 100937.
[Full Text]
-
AML with Prior MDS
- Peter Maslak
ASH Image Bank 2004 2004: 100956.
[Full Text]
-
Dysplastic Megakaryocyte
- Peter Maslak
ASH Image Bank 2004 2004: 100973.
[Full Text]
-
Refractory Anemia with Ringed Sideroblasts (RARS)
- John Lazarchick
ASH Image Bank 2004 2004: 100977.
[Full Text]
-
Acute Myeloid Leukemia with Multilineage Dysplasia
- Peter Maslak
ASH Image Bank 2004 2004: 101022.
[Full Text]
-
Dysplastic Megakaryocytes
- Peter Maslak
ASH Image Bank 2004 2004: 101023.
[Full Text]
-
Juvenile Myelomonocytic Leukemia
- Peter Maslak
ASH Image Bank 2004 2004: 101038.
[Full Text]
-
Acute Erythroleukemia
- Tsuyako Saito, Isao Miyoshi, Hirokuni Taguchi, and Masamichi Hara
ASH Image Bank 2004 2004: 101097.
[Full Text]
-
Refractory Anemia with Excess Blasts
- Peter Maslak
ASH Image Bank 2004 2004: 101103.
[Full Text]
-
Refractory Anemia with Excess Blasts
- Peter Maslak
ASH Image Bank 2004 2004: 101106.
[Full Text]
-
Refractory Anemia with Excess Blasts
- Peter Maslak
ASH Image Bank 2004 2004: 101110.
[Full Text]
-
Refractory Anemia with Excess Blasts-2
- Peter Maslak
ASH Image Bank 2004 2004: 101112.
[Full Text]
-
Hypocellular MDS
- Peter Maslak
ASH Image Bank 2004 2004: 101115.
[Full Text]
-
Refractory Anemia
- Peter Maslak
ASH Image Bank 2004 2004: 101134.
[Full Text]
-
Refractory Anemia with Ring Sideroblasts
- Peter Maslak
ASH Image Bank 2004 2004: 101135.
[Full Text]
-
Dysplastic Neutrophil
- Peter Maslak
ASH Image Bank 2004 2004: 101149.
[Full Text]
-
Pseudo Pelger-Huet Cell
- Peter Maslak
ASH Image Bank 2004 2004: 101151.
[Full Text]
-
Myelodysplastic Syndrome Associated with Isolated Del (5q) Chromosome Abnormality
- Peter Maslak
ASH Image Bank 2004 2004: 101163.
[Full Text]
-
Dyserythropoiesis
- Peter Maslak
ASH Image Bank 2004 2004: 101173.
[Full Text]
-
Dysmyelopoiesis
- Peter Maslak
ASH Image Bank 2004 2004: 101174.
[Full Text]
| Related ASH Education Book Articles |  |  |
-
Achievements in Understanding and Treatment of Myelodysplastic Syndromes
- Eva Hellström-Lindberg, Cheryl Willman, A. John Barrett, and Yogen Saunthararajah
Hematology 2000 2000: 110-132.
[Abstract]
[Full Text]
-
Myelodysplastic Syndromes
- Peter L. Greenberg, Neal S. Young, and Norbert Gattermann
Hematology 2002 2002: 136-161.
[Abstract]
[Full Text]
-
Myelodysplastic Syndrome
- Ghulam Mufti, Alan F. List, Steven D. Gore, and Aloysius Y.L. Ho
Hematology 2003 2003: 176-199.
[Abstract]
[Full Text]
-
Myelodysplastic Syndromes
- Alan F. List, James Vardiman, Jean-Pierre J. Issa, and Theo M. DeWitte
Hematology 2004 2004: 297-317.
[Abstract]
[Full Text]
Related ASH-SAP Chapter: |
 |
-
Chapter 9: Myelodysplastic syndrome and overlap syndromes
Copyright © 2001 by the American Society of Hematology.